Advanced Nucleic Acid Process Development
Producing satisfactory nucleic acid therapeutics is rapidly evolving, often challenged by molecular stability and technical complexity. Our expert team and state-of-the-art facilities offer specialized support and innovative approaches. We have experience developing novel processes outside the common platform processes used by established contract manufacturing organizations (CMOs) making oligonucleotides by solid phase synthesis or RNA using in vitro transcription.
The foundation of successful process development programs is based on the quality of analytical data. While we support quality by design (QbD) approaches, an understanding of the fundamental chemistry and biochemistry of the process is needed to make rational use of QbD experiments when developing novel processes. This integral background enables our team to identify and mitigate potential quality risks early on.
Integrated Laboratory Services
When your team needs additional CDMO support, our scientists are ready. Our state-of-the-art facilities and highly trained experts can add power to your project.